ICD-10 Diagnosis Code C54.1

Malignant neoplasm of endometrium

Diagnosis Code C54.1

ICD-10: C54.1
Short Description: Malignant neoplasm of endometrium
Long Description: Malignant neoplasm of endometrium
This is the 2019 version of the ICD-10-CM diagnosis code C54.1

Valid for Submission
The code C54.1 is valid for submission for HIPAA-covered transactions.

Code Classification
  • Neoplasms (C00–D48)
    • Malignant neoplasms of female genital organs (C51-C58)
      • Malignant neoplasm of corpus uteri (C54)

Information for Medical Professionals


Code Edits
The following edits are applicable to this code:
Diagnoses for females only - Diagnoses for females only.

Diagnostic Related Groups
The diagnosis code C54.1 is grouped in the following Diagnostic Related Group(s) (MS-DRG V35.0)

  • 736 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC
  • 737 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC
  • 738 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC
  • 739 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC
  • 740 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC
  • 741 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC

Convert to ICD-9
  • 182.0 - Malig neo corpus uteri (Approximate Flag)

Synonyms
  • Adenocarcinoma of endometrium
  • Adenosquamous cell carcinoma
  • Carcinosarcoma of uterus
  • Endometrial carcinoma
  • Endometrial carcinosarcoma
  • Endometrial stromal sarcoma
  • Endometrial stromal tumor
  • FIGO EC stage I
  • FIGO EC stage I A
  • FIGO EC stage I B
  • FIGO EC stage II
  • FIGO EC stage III
  • FIGO EC stage IIIB
  • FIGO EC stage IIIC1
  • FIGO EC stage IIIC2
  • FIGO EC stage IV
  • FIGO EC stage IVA
  • FIGO EC stage IVB
  • High grade endometrial stromal sarcoma
  • International Federation of Gynecology and Obstetrics endometrial cancer stage IIIA
  • Low grade endometrial stromal sarcoma
  • Malignant neoplasm of endometrium of corpus uteri
  • Malignant tumor involving an organ by direct extension from endometrium
  • Malignant tumor involving an organ by separate metastasis from endometrium
  • Malignant tumor involving bladder by direct extension from endometrium
  • Malignant tumor involving bladder by separate metastasis from endometrium
  • Malignant tumor involving left fallopian tube by direct extension from endometrium
  • Malignant tumor involving left fallopian tube by separate metastasis from endometrium
  • Malignant tumor involving left ovary by direct extension from endometrium
  • Malignant tumor involving left ovary by separate metastasis from endometrium
  • Malignant tumor involving rectum by direct extension from endometrium
  • Malignant tumor involving rectum by separate metastasis from endometrium
  • Malignant tumor involving right fallopian tube by direct extension from endometrium
  • Malignant tumor involving right fallopian tube by separate metastasis from endometrium
  • Malignant tumor involving right ovary by direct extension from endometrium
  • Malignant tumor involving right ovary by separate metastasis from endometrium
  • Malignant tumor involving vagina by direct extension from endometrium
  • Malignant tumor involving vagina by separate metastasis from endometrium
  • Malignant tumor involving vulva by direct extension from endometrium
  • Malignant tumor involving vulva by separate metastasis from endometrium
  • Primary adenosquamous carcinoma of endometrium
  • Primary malignant clear cell neoplasm of endometrium
  • Primary malignant mixed Mullerian neoplasm of endometrium
  • Primary malignant neoplasm of endometrium
  • Primary mixed adenocarcinoma of endometrium
  • Primary mucinous adenocarcinoma of endometrium
  • Primary papillary serous cystadenocarcinoma of endometrium
  • Primary serous adenocarcinoma of endometrium
  • Primary small cell carcinoma of endometrium
  • Primary squamous cell carcinoma of endometrium
  • Primary undifferentiated carcinoma of endometrium
  • pT1
  • pT1a
  • Sarcoma of endometrium
  • Sarcoma of uterus
  • Secondary malignant neoplasm of left fallopian tube
  • Secondary malignant neoplasm of left ovary
  • Secondary malignant neoplasm of rectum
  • Secondary malignant neoplasm of right fallopian tube
  • Secondary malignant neoplasm of right ovary
  • Secondary malignant neoplasm of vagina
  • Secondary malignant neoplasm of vulva
  • T1 : Endometrial tumor confined to corpus uteri
  • T1a : Tumor limited to endometrium
  • T1b : Endometrial tumor invades up to or less than one half of the endometrium
  • T1c : Endometrial tumor invades to more than one half of the endometrium
  • T2 : Endometrial tumor invades cervix, but does not extend beyond uterus
  • T2a : Endometrial tumor with endocervical glandular involvement
  • T2b : Endometrial tumor with cervical stromal invasion
  • T3 and/or cancer cells in ascites or peritoneal washings
  • T3b
  • T4 : Endometrial tumor invades bladder mucosa and/or bowel mucosa

Table of Neoplasms

The code C54.1 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

The Tabular must be reviewed for the complete diagnosis code.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»endometrium (gland) (stroma)
C54.1C79.82D07.0D26.1D39.0D49.59
»stroma, endometrial
C54.1C79.82D07.0D26.1D39.0D49.59
»uterus, uteri, uterine
  »endometrium
C54.1C79.82D07.0D26.1D39.0D49.59

Information for Patients


Uterine Cancer

Also called: Endometrial cancer

The uterus, or womb, is the place where a baby grows when a women is pregnant. There are different types of uterine cancer. The most common type starts in the endometrium, the lining of the uterus. This type is also called endometrial cancer.

The symptoms of uterine cancer include

  • Abnormal vaginal bleeding or discharge
  • Trouble urinating
  • Pelvic pain
  • Pain during intercourse

Uterine cancer usually happens after menopause. It is more common in women who have obesity. You also have a higher risk if you took estrogen-only hormone replacement therapy (menopausal hormone therapy) for many years.

Tests to find uterine cancer include a pelvic exam, imaging tests, and a biopsy. The most common treatment is a hysterectomy, which is surgery to remove the uterus. Sometimes the surgery also removes the ovaries and fallopian tubes. Other treatments include hormone therapy, radiation therapy, and chemotherapy. Some women get more than one type of treatment.

NIH: National Cancer Institute

  • Choriocarcinoma (Medical Encyclopedia)
  • Endometrial biopsy (Medical Encyclopedia)
  • Endometrial cancer (Medical Encyclopedia)
  • Uterine Cancer (Centers for Disease Control and Prevention)
  • What to Know about Brachytherapy (A Type of Internal Radiation Therapy) - NIH - Easy-to-Read (National Cancer Institute)
  • What to Know about External Beam Radiation Therapy - NIH - Easy-to-Read (National Cancer Institute)

[Read More]

ICD-10 Footnotes

General Equivalence Map Definitions
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.

  • Approximate Flag - The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
  • No Map Flag - The no map flag indicates that a code in the source system is not linked to any code in the target system.
  • Combination Flag - The combination flag indicates that more than one code in the target system is required to satisfy the full equivalent meaning of a code in the source system.

Present on Admission
The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement.

Previous Code
C54.0
Next Code
C54.2